Arthur T. Sands
2008 - Lexicon Pharmaceuticals
In 2008, Arthur T. Sands earned a total compensation of $1.4M as President, Chief Executive Officer and Director at Lexicon Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
| Option Awards | $872,678 |
|---|---|
| Salary | $557,500 |
| Other | $6,470 |
| Total | $1,436,648 |
Sands received $872.7K in option awards, accounting for 61% of the total pay in 2008.
Sands also received $557.5K in salary and $6.5K in other compensation.
Rankings
In 2008, Arthur T. Sands' compensation ranked 3,321st out of 9,135 executives tracked by ExecPay. In other words, Sands earned more than 63.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,321 out of 9,135 | 64th |
Division Manufacturing | 1,181 out of 3,436 | 66th |
Major group Chemicals And Allied Products | 221 out of 815 | 73rd |
Industry group Drugs | 123 out of 597 | 79th |
Industry Pharmaceutical Preparations | 93 out of 408 | 77th |
Source: SEC filing on March 18, 2011.
Sands' colleagues
We found five more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2008.
2008
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2008
Julia Gregory
Lexicon Pharmaceuticals
Chief Financial Officer
2008
Alan Main
Lexicon Pharmaceuticals
Executive Vice President of Pharmaceutical Research
2008
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2008
James Tessmer
Lexicon Pharmaceuticals
Vice President, Finance and Accounting
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021